$436 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 10 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ODT | Buy | ODONATE THERAPEUTICS INC | $197,785,000 | -26.1% | 14,047,250 | +1.8% | 45.38% | +3.8% |
HRTX | Sell | HERON THERAPEUTICS INC | $150,933,000 | -19.9% | 5,818,541 | -2.2% | 34.63% | +12.6% |
RCKT | ROCKET PHARMACEUTICALS INC | $43,948,000 | -39.8% | 2,965,485 | 0.0% | 10.08% | -15.4% | |
LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $36,578,000 | -56.1% | 3,878,893 | -6.3% | 8.39% | -38.3% |
PBYI | New | PUMA BIOTECHNOLOGY INC | $5,035,000 | – | 247,400 | +100.0% | 1.16% | – |
OPHT | New | OPHTHOTECH CORP | $720,000 | – | 600,000 | +100.0% | 0.16% | – |
PRTA | New | PROTHENA CORP PLC | $490,000 | – | 47,610 | +100.0% | 0.11% | – |
EQ | New | EQUILLIUM INC | $386,000 | – | 47,343 | +100.0% | 0.09% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
4 | 2024-02-14 |
4 | 2024-02-02 |
4 | 2023-12-18 |
13F-HR | 2023-11-14 |
4 | 2023-10-13 |
13F-HR | 2023-08-14 |
3 | 2023-06-01 |
4 | 2023-06-01 |
4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.